High-deductible health plans have a role to play, but it's important that they aren't used in such a way as to create a disincentive of the use of a consumer's benefits, said Niteesh Choudhry, MD, PhD, associate professor of medicine at Harvard Medical School.
High-deductible health plans have a role to play, but it's important that they aren't used in such a way as to create a disincentive of the use of a consumer's benefits, said Niteesh Choudhry, MD, PhD, associate professor of medicine at Harvard Medical School.
Transcript (slightly modified)
How can we ensure that patients in high-deductible health plans still utilize high-value services?
I think there are a couple things to consider. So these high-deductible health plans (HDHPs) no doubt have a role to play; the economic realities of our situation and spending and costs and the needs of employers are not things that people are making up. And so, in principle, HDHPs may actually lead to lots of good things in healthcare.
The problem, at least in the short term, are those patients who are most at risk and are therefore making choices that may be not in their interest. And so we somehow need to save either those services or those individuals, and find a way to actually provide them with benefits that would not create a disincentive for their use. So, for example, if we were to link HDHPs with value-based insurance design is an example where we sort of identify high-value services like prescription drugs or certain individuals or certain procedures, and we say, “Okay, those things should have no copayments or no deductibles, or lower copayments or deductibles than the standard benefit.”
Right now HDHPs often have $0 coverage for vaccination, which is probably a valuable service for most people, but also for primary care visits and, as you know, there’s lots of debate about the value of primary care today. As a general internist you know I can appreciate the fact that it’s not always clear that what we do in a well visit leads to better outcomes, and so that’s not actually value-based insurance design.
Instead what we should say is $0 dollar copayments for those services that we know to be of value.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More